GlobeNewswire by notified

Auction details treasury bills

Share

Auction date August 19, 2020                     

Maturity date Issue volume, SEK million Days (Act/360) ISIN code
2020-11-18 12,500 89 SE0014705034

Settlement date August 21, 2020

Bids have to be entered by 11.00 on August 19, 2020

Bid only through dealers approved by the Swedish National Debt Office

For more information, please contact: 

The funding desk
+ 46 8 613 4780
Fo@riksgalden.se

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

EBC Financial Group (Cayman) Limited Granted Full Regulatory Licence from the Cayman Islands Monetary Authority (CIMA)28.3.2024 11:53:45 CET | Press release

EBC Financial Group strengthens its global presence with full CIMA licence, underscoring the group’s commitment to stringent global regulatory standards HONG KONG, March 28, 2024 (GLOBE NEWSWIRE) -- EBC Financial Group (EBC Group or EBC) is pleased to announce that its Cayman Islands subsidiary, EBC Financial Group (Cayman) Limited, has been awarded a full Cayman Islands Monetary Authority (CIMA) licence. This significant achievement marks a major advancement in EBC's global regulatory portfolio, following its existing accreditations from the UK's Financial Conduct Authority (FCA) and the Australian Securities and Investments Commission (ASIC). Within CIMA's strict regulatory framework, EBC will offer more comprehensive financial services, including trusts, securities, futures, and funds, specifically catering to retail, professional, high-net-worth individuals and institutional investors. The Cayman Islands, recognized as a premier offshore financial centre, gathers 90% of the world's

Changes in financial calender28.3.2024 11:30:00 CET | Press release

According to the AS Pro Kapital Grupp 2024 financial calendar, the Company should publish its audited financial results for 2023 on 30 April 2024. AS Pro Kapital Grupp announces that it will publish its audited financial results for 2023 earlier than foreseen in the Company's financial calendar and the audited results for 2023 will be published between 10-12 April 2024. Ann-Kristin Kuusik CFO Phone: +372 614 4920 e-mail: prokapital@prokapital.ee

Meriaura Group Plc’s annual report for 2023 published28.3.2024 11:30:00 CET | Press release

Meriaura Group Plc Company Announcement 28 April 2024 at 11.30 a.m. (CET) Meriaura Group Plc’s annual report for 2023 published Meriaura Group Plc’s annual report including the annual accounts, the report of the Board of Directors and the auditor’s report for the year 2023 has been published. The annual report is available at the company’s website https://meriauragroup.com/investors/reports-and-presentations/financial-reports/ and it’s also attached to this announcement. The annual report is available in pdf format in Finnish and in English. MERIAURA GROUP PLC Further information: CEO Kirsi Suopelto Tel: +358 505 602 349 Email: kirsi.suopelto@meriaura.com Meriaura Group in brief Meriaura Group has two business areas: Marine Logistics and Renewable Energy. Marine Logistics business is carried out by Meriaura Ltd, which is a major provider of transport for bulk cargo and demanding project deliveries in Northern Europe, especially in the Baltic Sea and North Sea regions. The company provi

Calibre Enters Pre-Commissioning and Commissioning Contract with Reliable Controls Corporation and Executes A Gold Prepayment28.3.2024 11:00:16 CET | Press release

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Calibre Mining Corp. (TSX: CXB; OTCQX: CXBMF) (“Calibre” or the “Company”) is pleased to announce the Company has entered into a key pre-commissioning and commissioning contract with Reliable Controls Corporation of Salt Lake City (“RCC”) for the Company’s Valentine Gold Mine (“VGM”) in Newfoundland and Labrador. The Company has also executed a US$60 million short term, gold prepayment agreement with Asahi Refining USA Inc. (“Asahi”), pursuant to which Asahi has agreed to purchase a total of 27,600 ounces of gold from the Company, comprising less than 10% of the Company’s expected 2024 gold production. Darren Hall, President and Chief Executive Officer of Calibre, stated: “With construction at Valentine 61% complete I remain confident in our ability to deliver first gold during H1, 2025. To further derisk delivery, I am pleased to announce that we have secured RCC, a team of highly experienced commissioning experts to lead

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors28.3.2024 11:00:00 CET | Press release

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to its board of directors effective April 2, 2024. “Dr. Gallagher is the sixth director to join our board of directors in the past twelve months as we continue to refresh and strengthen the Board governance and oversight required for the next stage of the Company’s development and growth,” said Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks. “His experience and leadership in leading multiple development programs through to global regulatory approval will support our efforts to rapidly advance our ‘5 by 5’ programs into clinical studies and our continued pipeline expansion of novel antibody-drug conjugates and multispecific antibodies in the years a

HiddenA line styled icon from Orion Icon Library.Eye